Insider screener

Period: 12 months Type of trade: Sold × Plan: Discretionary × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,113 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,113 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,113 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,113 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,113 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,113 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,113 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
23 Feb 2026
Sold at will
$230.66K 4,150 at 55.58
20.4%
Not planned
23 Feb 2026
Luke Thomas Friang Chief Product & Tech Officer
Sold at will 3×
$210.21K 19,609 at 10.72
3.9%
Not planned
23 Feb 2026
Sean Grant Chief Financial Officer
Sold at will
$207.78K 4,949 at 41.98
4.2%
Not planned
23 Feb 2026
Sold at will 2×
$207.46K 11,264 at 18.42
3.3%
Not planned
23 Feb 2026
Laurie A Minard VP, Human Resources
Sold at will
$206.98K 837 at 247.28
12.6%
Not planned
23 Feb 2026
Patrick John Finn President and COO
Sold at will
$200.57K 4,294 at 46.71
1.5%
Not planned
23 Feb 2026
E Scott Urdang Director
Sold at will
$189.48K 4,000 at 47.37
3.0%
Not planned
23 Feb 2026
Lance A Berry EVP, COO, CFO & Treasurer
Sold at will
$187.23K 4,981 at 37.59
3.2%
Not planned
23 Feb 2026
Mitchel D Colburn VP of Plan, Eng, & Const (IPC)
Sold at will
$185.44K 1,300 at 142.65
34.9%
Not planned
23 Feb 2026
Column Group III Gp, LP 10% owner · indirect
Sold at will 2×
$182.74K 306,000 at 0.60
13.5%
Not planned
23 Feb 2026
Steve Ming Lo Chief Accounting Officer
Sold at will 3×
$181.83K 16,962 at 10.72
9.1%
Not planned
23 Feb 2026
Philip L Hawkins Director
Sold at will
$181.10K 5,536 at 32.71
26.7%
Not planned
23 Feb 2026
Anthony Morgan Group President
Sold at will
$179.81K 3,387 at 53.09
6.9%
Not planned
23 Feb 2026
Michael E. Alexander Group President
Sold at will
$179.73K 3,387 at 53.07
4.7%
Not planned
23 Feb 2026
Filip Janku Chief Medical Officer
Sold at will
$179.16K 9,189 at 19.50
12.2%
Not planned
23 Feb 2026
Serge Saxonov Chief Executive Officer
Sold at will
$178.93K 9,632 at 18.58
0.9%
Not planned
23 Feb 2026
Adrian Helfert CIO, Multi-Asset Inv.
Sold at will
$174.72K 10,772 at 16.22
6.2%
Not planned
23 Feb 2026
Adam Taich Chief Financial Officer
Sold at will
$166.59K 8,968 at 18.58
3.0%
Not planned
23 Feb 2026
Elaine M. Birkemeyer Chief Financial Officer
Sold at will 2×
$156.14K 5,518 at 28.30
3.7%
Not planned
23 Feb 2026
Mike Rosinus Director · indirect
Sold at will
$150.80K 5,000 at 30.16
3.1%
Not planned
23 Feb 2026
Sold at will
$149.17K 5,256 at 28.38
0.2%
Not planned
23 Feb 2026
Benjamin J. Hindson See Remarks
Sold at will
$145.38K 7,826 at 18.58
1.8%
Not planned
23 Feb 2026
Julia A Hilton VP and General Counsel
Sold at will
$142.79K 1,000 at 142.79
30.2%
Not planned
23 Feb 2026
John E Davis Chief Commercial Officer
Sold at will
$141.82K 3,773 at 37.59
1.9%
Not planned
23 Feb 2026
Sold at will
$141.50K 566 at 250.00
11.5%
Not planned
23 Feb 2026
Sold at will
$140.95K 5,000 at 28.19
0.8%
Not planned
23 Feb 2026
Erik J Anderson Director · indirect
Sold at will
$138.22K 10,000 at 13.82
1.4%
Not planned
23 Feb 2026
Joseph R Young SVP, Finance, Chief Acct Offcr
Sold at will
$130.86K 3,117 at 41.98
4.6%
Not planned
23 Feb 2026
Richard Edward Colburn III Chief Product & Tech Officer
Sold at will
$129.80K 2,500 at 51.92
30.2%
Not planned
23 Feb 2026
Kristie Burns Sr. VP Mktg & Clinical Affairs
Sold at will 2×
$125.61K 4,439 at 28.30
4.8%
Not planned
23 Feb 2026
Jean F Holloway SVP, General Counsel
Sold at will
$115.73K 3,079 at 37.59
2.0%
Not planned
23 Feb 2026
David Lee Johnson Chief Operating Officer
Sold at will
$108.28K 2,579 at 41.98
5.3%
Not planned
23 Feb 2026
Fabian Gomez President
Sold at will
$100.94K 6,223 at 16.22
4.8%
Not planned
23 Feb 2026
Adam Laponis Chief Financial Officer
Sold at will
$97.39K 2,085 at 46.71
1.6%
Not planned
23 Feb 2026
Erica S Bowman Vice President
Sold at will
$94.26K 1,276 at 73.88
28.4%
Not planned
23 Feb 2026
William D. Turner Chief Regulatory Officer
Sold at will
$91.82K 2,187 at 41.98
4.6%
Not planned
23 Feb 2026
Marshall S. Stanton SVP, Clinical & MD Affair
Sold at will
$91.08K 2,423 at 37.59
5.3%
Not planned
23 Feb 2026
Robert Brenner Chief Medical Officer
Sold at will
$90.31K 2,151 at 41.98
4.1%
Not planned
23 Feb 2026
Sold at will 5×
$89.48K 2,628 at 34.05
34.9%
Not planned
23 Feb 2026
Matthew Lockridge Head, U.S. Value Inv.
Sold at will
$87.25K 5,379 at 16.22
6.5%
Not planned
23 Feb 2026
Robert F. Werner Chief Accounting Officer
Sold at will
$79.08K 1,693 at 46.71
3.0%
Not planned
23 Feb 2026
Sold at will
$78.07K 6,500 at 12.01
0.2%
Not planned
23 Feb 2026
Allen Wilkinson SVP, Chief Accounting Officer
Sold at will
$72.61K 248 at 292.79
37.7%
Not planned
23 Feb 2026
Sold at will
$69.02K 2,000 at 34.51
0.0%
Not planned
23 Feb 2026
Paula Green SVP of Human Resources
Sold at will
$68.43K 1,465 at 46.71
1.2%
Not planned
23 Feb 2026
Minardo John Chief Legal Officer
Sold at will
$66.44K 17,439 at 3.81
4.4%
Not planned
23 Feb 2026
Laurence Matthew Skelton Chief Commercial Officer
Sold at will
$66.42K 1,582 at 41.98
2.4%
Not planned
23 Feb 2026
Amy Horton VP, Chief Accounting Officer
Sold at will
$65.06K 1,731 at 37.59
1.3%
Not planned
23 Feb 2026
Jorge Titinger Director
Sold at will
$60.13K 1,200 at 50.11
7.9%
Not planned
23 Feb 2026
Michael Shetzline SVP, CMO, Head-Res&Drug
Sold at will
$59.32K 15,570 at 3.81
2.8%
Not planned
Showing 16,101–16,150 of 23,113. ← Newer Page 323 of 463 Older →